Saracatinab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Jewish Health
Overview
Saracatinab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Saracatinab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Saracatinab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.